Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Honeywell introduces Experion PKS Highly Integrated Virtual Environment (HIVE) June 10, 2019 Microchip Technology introduces PL360B PLC modem June 12, 2018 Haydon Kerk announces launch of 3-D-printed leadscrew-nut insert prototype service January 12, 2018